These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The pharmacology of selective inhibition of COX-2. Grosser T. Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913 [Abstract] [Full Text] [Related]
3. Role of prostacyclin in the cardiovascular response to thromboxane A2. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Science; 2002 Apr 19; 296(5567):539-41. PubMed ID: 11964481 [Abstract] [Full Text] [Related]
4. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Badimon L, Vilahur G, Rocca B, Patrono C. Cardiovasc Res; 2021 Jul 27; 117(9):2001-2015. PubMed ID: 33484117 [Abstract] [Full Text] [Related]
5. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ. J Immunol; 2001 Sep 01; 167(5):2831-8. PubMed ID: 11509629 [Abstract] [Full Text] [Related]
6. Cyclooxygenase pathways. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. Acta Biochim Pol; 2014 Sep 01; 61(4):639-49. PubMed ID: 25343148 [Abstract] [Full Text] [Related]
13. Cyclooxygenase inhibition and thrombogenicity. Catella-Lawson F, Crofford LJ. Am J Med; 2001 Feb 19; 110 Suppl 3A():28S-32S. PubMed ID: 11173047 [Abstract] [Full Text] [Related]
14. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR, Sperling RS, Reicin A, Gertz BJ. Am Heart J; 2003 Oct 19; 146(4):591-604. PubMed ID: 14564311 [Abstract] [Full Text] [Related]
15. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Tapiero H, Ba GN, Couvreur P, Tew KD. Biomed Pharmacother; 2002 Jul 19; 56(5):215-22. PubMed ID: 12199620 [Abstract] [Full Text] [Related]
17. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Ruan KH, Deng H, So SP. Biochemistry; 2006 Nov 28; 45(47):14003-11. PubMed ID: 17115695 [Abstract] [Full Text] [Related]
18. Role of prostaglandins in pregnancy-induced hypertension. Satoh K, Seki H, Sakamoto H. Am J Kidney Dis; 1991 Feb 28; 17(2):133-8. PubMed ID: 1899531 [Abstract] [Full Text] [Related]
19. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Davidge ST, Baker PN, Laughlin MK, Roberts JM. Circ Res; 1995 Aug 28; 77(2):274-83. PubMed ID: 7614714 [Abstract] [Full Text] [Related]
20. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors. Eskildsen MP, Hansen PB, Stubbe J, Toft A, Walter S, Marcussen N, Rasmussen LM, Vanhoutte PM, Jensen BL. Hypertension; 2014 Sep 28; 64(3):551-6. PubMed ID: 24914192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]